Penn Med partners with Regeneron to research method of delivering antibody cocktail
Regeneron Pharmaceutical's antibody cocktail was granted an Emergency Use Authorization by the United States Food and Drug Administration on Nov. 21 for use in high-risk patients with mild to moderate cases of COVID-19.



















